SCHEMBL9604021

SCHEMBL9604021

Cc1c(C)c(C)c2oc(-c3ccc(-c4cccc5c4oc4ccccc45)cc3)nc2c1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.47
KDM4E B2RXH2 5/20 0.42
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 3/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
TSHR P16473 2/20 0.42
CYP2C19 P33261 2/20 0.42
HPGD P15428 2/20 0.38
CYP2D6 P10635 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
PRKDC P78527 2/20 0.37
PIK3CD O00329 1/20 0.37
PIK3CB P42338 1/20 0.37
GGPS1 O95749 1/20 0.36
TOP2A P11388 1/20 0.35
EDNRB P24530 1/20 0.35
EDNRA P25101 1/20 0.35
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9604013 0.85 ALOX5 (0.47) ALOX5KDM4EALDH1A1HSD17B10CYP1A2
SCHEMBL9604019 0.84 ALOX5 (0.48) ALOX5KDM4EALDH1A1HSD17B10CYP1A2
SCHEMBL9604029 0.82 ALOX5 (0.49) ALOX5KDM4EALDH1A1HSD17B10CYP1A2
SCHEMBL9604044 0.81 NPC1 (0.52) ALOX5KDM4EALDH1A1HSD17B10CYP1A2
SCHEMBL9604018 0.81 ALOX5 (0.48) ALOX5KDM4EALDH1A1HSD17B10TSHR
SCHEMBL9604028 0.81 ALOX5 (0.50) ALOX5KDM4EALDH1A1HSD17B10CYP1A2
SCHEMBL9604034 0.79 ALOX5 (0.51) ALOX5KDM4EALDH1A1HSD17B10HPGD
SCHEMBL9604035 0.78 DHODH (0.53) ALOX5KDM4EALDH1A1HSD17B10HPGD
SCHEMBL9603967 0.78 NPC1 (0.55) ALOX5KDM4EALDH1A1HSD17B10CYP1A2
SCHEMBL20714156 0.78 ALOX5 (0.50) ALOX5KDM4EALDH1A1HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546584-B2 Benzoxazole derivative, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-10-01 US disclosed
US-8546584-B2 Benzoxazole derivative, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-10-01 US disclosed
US-20120132896-A1 Benzoxazole Derivative, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD 2012-05-31 US disclosed
US-20120132896-A1 Benzoxazole Derivative, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120132896-A1 Benzoxazole Derivative, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device XDH, AOX1, CYP4X1 ALOX5 720/4885KDM4E 2142/4885ALDH1A1 112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.